1. Home
  2. VRME vs ALZN Comparison

VRME vs ALZN Comparison

Compare VRME & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.65

Market Cap

10.4M

Sector

Technology

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$2.11

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
ALZN
Founded
1999
2016
Country
United States
United States
Employees
N/A
7
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
8.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VRME
ALZN
Price
$0.65
$2.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$1.50
$42.00
AVG Volume (30 Days)
468.9K
99.7K
Earning Date
11-14-2025
12-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$1.88
52 Week High
$5.00
$12.06

Technical Indicators

Market Signals
Indicator
VRME
ALZN
Relative Strength Index (RSI) 38.56 43.48
Support Level $0.67 $2.10
Resistance Level $0.76 $2.27
Average True Range (ATR) 0.07 0.13
MACD 0.00 0.01
Stochastic Oscillator 4.48 32.06

Price Performance

Historical Comparison
VRME
ALZN

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: